Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors

Clinical trial NCT00372567 · TERMINATED

Trial details

NCT number: NCT00372567
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumor

Start date: 2007-06-01
Primary completion: 2009-11-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.